I
Icosapent ethyl (Vascepa)
pharmaceuticalMentioned in 1 video
An EPA-only ethyl ester prescription omega-3 indicated for reducing cardiovascular events, with FDA stating it does not cause clinically significant bleeding.
An EPA-only ethyl ester prescription omega-3 indicated for reducing cardiovascular events, with FDA stating it does not cause clinically significant bleeding.